Merck bags EU approval for Keytruda chemo combo therapy for NSCLC
Merck has bagged the European Commission approval for the combination of its anti-PD-1 cancer immunotherapy Keytruda (pembrolizumab) with Lilly’s chemotherapy
Continue reading
Tag: Keytruda
Alkermes to evaluate ALKS 4230, pembrolizumab combo for solid tumors
Irish biopharma company Alkermes said that it has expanded an ongoing phase 1 trial for its immuno oncology drug ALKS
Continue readingMerck lung cancer drug Keytruda plus chemo gets FDA approval for NSCLC
Merck’s cancer immunotherapy Keytruda (pembrolizumab) in combination with chemotherapy has been approved by the US Food and Drug Administration (FDA)
Continue reading
